期刊文献+

螺内酯抑制心肌细胞凋亡机制的初步研究 被引量:7

Mechanism of spironolactone inhibiting cardiac myocyte apoptosis
下载PDF
导出
摘要 目的初步探讨螺内酯(spironolactone,SPI)抑制心肌细胞凋亡的机制以及心肌梗死后对心室重构的影响。方法 45只SD大鼠分为3组:假手术假手术组、心肌梗死(myocardial infarction,MI)组和心肌梗死后SPI干预组。测量大鼠左心室功能、观察标本病理形态改变,缺口末端标记法(TUNEL)检测细胞凋亡程度,免疫组化观察半胱氨酸蛋白酶8(caspase8)、半胱氨酸蛋白酶9(caspase9)。结果 (1)MI组心功能较假手术组明显下降,SPI干预组较MI组改善;(2)假手术组心肌结构完整,MI组心肌结构损害严重,SPI组心肌结构损害较轻;(3)与假手术组相比,MI组凋亡细胞数显著增加,差异有统计学意义(P<0.05);与MI组相比,SPI组心肌细胞凋亡数显著减少,差异有统计学意义(P<0.01);(4)与假手术组相比,MI组半胱氨酸蛋白酶8、半胱氨酸蛋白酶9表达显著增加,差异有统计学意义(P<0.01);与MI相比,SPI组半胱氨酸蛋白酶8表达无明显差异,而半胱氨酸蛋白酶9表达明显下降,差异有统计学意义(P<0.01)。结论螺内酯通过抑制细胞凋亡改善了心室重构和心力衰竭的发生发展,可能通过凋亡的内源性途径抑制了心肌细胞的凋亡。 Objectives To investigate the mechanism of spironolactone(SPI) on myocardial cell apoptosis and the influence on myocardial remodeling in rat hearts after myocardial infarction(MI).Methods MI was achieved by permanent occlusion of the left coronary artery.Sprague-Dawley rats were divided into three groups:(1) sham group; (2) untreated MI group; (3) SPI-treated MI group.MacLab left ventricular developed pressure (LVDP),+dp/dtmax and-dp/dt,max were compared within the three groups.Expressions of caspase8,caspase9 in myocardium were measured by immunohistochemistry.Myocardial apoptosis was determined by TUNEL stain.Results (1) Cardiac function in MI group significantly decreased compared to that in sham group;SPI group was better than MI group.(2) Cardiomyocyte injury was more severe in MI group than in SPI group.(3)The number of apoptotic cells significantly increased in MI group (P〈0.05),while SPI markedly inhibited myocardial cell apoptosis after MI (P〈0.01).(4) Expressions of caspase8 and caspase9 significantly increased in MI group than in sham group (P〈0.01).Caspase8 in SPI group showed no significant difference compared with that in MI group (P〉0.05).Caspase9 in SPI group significantly decreased compared with that in MI group (P〈0.01).Conclusions SPI may protect cardiomyocytes from MI and improve myocardial remodeling by inhibiting their apoptosis by intrinsic pathway.
出处 《岭南心血管病杂志》 2014年第4期547-550,552,共5页 South China Journal of Cardiovascular Diseases
关键词 心肌梗死 心室重构 螺内酯 凋亡 半胱氨酸蛋白酶8 半胱氨酸蛋白酶9 myocardial infarction myocardial remodeling spironolactone apoptosis caspase 8 caspase 9
  • 相关文献

参考文献10

  • 1PHELAN D, THAVENDIRANATHAN P, COLLIER P, et al. Aldosterone antagonists improve ejection fraction and functional capacity independently of functional class: a metaanalysis of randomised controlled trials [ J ]. Heart, 2012, 98 (23) : 1693- 1700.
  • 2FRACCAROLLO D, BERGER S, GALUPPO P, et al. Deletion of cardiomyecyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction [ J ]. Circulation, 2011, 123(1): 400-408.
  • 3TIAN X F, CUI M X, YANG S W, et al. Cell death, dysglycemia and myocardial infarction [J ]. Biomed rep, 2013, 1(3) : 341-346.
  • 4TAKEDA M, TATSUMI T A, MATSUNAGA S, et al. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts[J]. Hypert Res, 2007,30 (30) : 427-437.
  • 5KONSTAM M A, THOMAS I, UDELSON J, et al.Ventricular remodeling in heart failure: a credible surrogate endpoint [J ]. JCard Failure, 2003, 9(5): 350-353.
  • 6MANI K. Programmed cell death in cardiac myocytes: strategies to maxim(ze postisehemic salvage [J]. Heart Fail Rev, 2008, 13(2) : 193-209.
  • 7IVANES F, SUSEN S, MOUQUET F, et al. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure[J].Eur Heart J, 2012, 33(2) : 191-202.
  • 8SANJIV J S, JOHN F H, NANCY K. SWEITZER, et al. Baseline characteristics of patients in the treatment of preservedcardiac function heart failure with an aldosterone antagonist trial, circulation[J]. Heart Failure, 2013, 6(2) : 184-192.
  • 9LI H, ZHU H, XU C J, et al. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis[J]. Cell , 1998, 94(4): 491-501.
  • 10LALLER L, CAMON P F, JUIN P, et al. Bax activation and mitochondrial insertion during apoptosis [ J ]. Apoptosis, 2007, 12(5) : 887-896.

同被引文献52

  • 1杨彩鸾.卡托普利联合美托洛尔治疗老年慢性心力衰竭患者的近期与远期疗效[J].中国老年学杂志,2014,34(1):220-221. 被引量:46
  • 2SU X, CHEN HL, WANG ZY, et al. Relationship between tu- mour location and preoperative seizure incidence in patients with gliomas: a systematic review and meta-analysis [J]. Epileptic Disord, 2015,17(4) :397-408.
  • 3KARPEL-MASSLER G, B M, SHU, et al. TICI0/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by sup- pression of Mcl-1 and its binding partners in vitro and in vivo [ J ]. Oncotarget, 2015,6 ( 34 ) : 36456-36471.
  • 4CHEN L, LI X, LIU L, et al. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-3,- lyase function [ J ]. Oncol Rep, 2015,33 ( 3 ) : 1465-1474.
  • 5TSO JL, SHUAI Y, MENJIVAR JC, et al. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase express- ing-glioblastoma stem cells to clinically relevant dose of temo- zolomide [J]. nol Cancer, 2015,14( 1 ) : 1-17.
  • 6MCDONALD KL, TABONE T, NOWAK AK, et al. Somatic muta- tions in glioblastoma are associated with methylguanine-DNA methyltransferase methylation [ J ]. Oncol Lett, 2015,9 ( 5 ) : 2063- 2067.
  • 7WANG L, YE X, CAI X, el al. Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells [J]. Oncotarget, 2015,6 (20) : 18027- 18037.
  • 8ZANOTTO-FILHO A, BRAGANHOL E, KLAFKE K, et al. Au- tophagy inhibition improves the efficacy of curcumin/temozolo- mide combination therapy in glioblastomas [J]. Cancer Lett, 2015,358 (2) : 220-231.
  • 9刘明伟,杨利荣.醛固酮与冠心病的研究现状[J].中华实用诊断与治疗杂志,2009,23(10):941-943. 被引量:2
  • 10贺庆芝,曾怀才,于伟霞,李国庆,易岚.姜黄素致HepG-2细胞的凋亡作用及对bcl-2/bax表达的影响[J].实用医学杂志,2010,26(3):358-360. 被引量:14

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部